I recently had the pleasure to spend time with the team at Applied Clinical Trials. Following our discussion they published an interview in the September edition of Applied Clinical Trials Magazine.
The interview is titled “Workforce Readiness Technology Minimizes Risk in Clinical Trials” and it explores how ArcheMedX is enabling Sponsors, CROs, and other trial stakeholders to improve clinical trial readiness.
Here’s the introduction and the full interview can be found below. Enjoy!
“Clinical trials often encounter operational challenges and sponsors and CROs seek effective site-readiness practices. In this interview, Joel B. Selzer, co-founder and CEO, ArcheMedX, Inc., discusses the impact that healthcare technology has on clinical trials, focusing on the development of the company’s workforce readiness platform.”
Related Post
AI Will Not Close the Readiness Gap in Clinical Trials. It Will Expose It.
The risk in an AI-first trial is not that teams use the tools. It is…
Joel Selzer
The Earliest Warning Sign: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
Most protocol deviations start as human problems, not operational ones, but risk-based monitoring typically relies…
Brian S McGowan, PhD
Fresh Starts, Real Readiness: Turning Site Initiation into a Trial Success Multiplier
By leveraging the Fresh Start Effect at site initiation and shifting from passive training to…
